These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 5907972)

  • 1. Toleration and absorption of sodium para-aminosalicylate and para-aminosalicylic acid (neopasalate). Comparison with other forms of para-aminosalicylic acid.
    Yue WY; Cohen SS
    Dis Chest; 1966 Feb; 49(2):165-74. PubMed ID: 5907972
    [No Abstract]   [Full Text] [Related]  

  • 2. Thrombocytopenia following administration of para-aminosalicylic acid.
    Feigin RD; Zarkowsky HF; Shearer W; Anderson DC
    J Pediatr; 1973 Sep; 83(3):502-3. PubMed ID: 4541998
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of insulin on isoniazid and para-aminosalicylic acid metabolism in patients with pulmonary tuberculosis].
    Savula MM; Kiselova ES
    Probl Tuberk; 1974; (8):43-6. PubMed ID: 4409368
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of sodium para-aminosalicylate on the concentration of isoniazid (tubazid) in the blood of patients with tuberculosis].
    Kozulitsina TI; Korotaev GA
    Ter Arkh; 1969; 41(10):94-7. PubMed ID: 5359356
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum transaminase levels during treatment with isoniazid, streptomycin and PAS.
    Smith JM; Springett VH
    Tubercle; 1966 Sep; 47(3):245-9. PubMed ID: 5971411
    [No Abstract]   [Full Text] [Related]  

  • 6. Inactivation of isoniazid (INH) in Swedish tuberculous patients before and during treatment with para-aminosalicylic acid (PAS).
    Hanngren A; Borgå O; Sjöqvist F
    Scand J Respir Dis; 1970; 51(1):61-9. PubMed ID: 5456864
    [No Abstract]   [Full Text] [Related]  

  • 7. [Acute renal failure following para-aminosalicylic-acid therapy].
    Csata S; Szendi L; Koller O
    Acta Chir Acad Sci Hung; 1975; 16(2):151-4. PubMed ID: 1227221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Studies on the metabolism of para-aminosalicylic acid in the body. VI. Absorption, tolerance and therapeutic effect of Napashin in double gastro-enteric coating].
    Nikodemowicz E; Owsiñski M; Kamiñska M; Ostrowska A; Rapf T
    Gruzlica; 1971 Nov; 39(11):1113-21. PubMed ID: 5137653
    [No Abstract]   [Full Text] [Related]  

  • 9. [Administration by slow phleboclysis of isoniazid and para-aminosalicylic acid in the treatment of tuberculosis. Therapeutic effects and blood levels of the drug].
    Mariani B; Bisetti A; Monzali G
    G Ital Mal Torace; 1967; 21(2):81-92. PubMed ID: 5602966
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 1. Comparison of rifampicin-ethambutol-isoniazid with streptomycin-paraminosalcylic acid-isoniazid in the original treatment of pulmonary tuberculosis patients].
    Kekkaku; 1971 Oct; 46(10):393-9. PubMed ID: 5147895
    [No Abstract]   [Full Text] [Related]  

  • 11. [Chemotherapy research on tuberculosis in various countries].
    Kekkaku; 1985 May; 60(5):287-92. PubMed ID: 3897687
    [No Abstract]   [Full Text] [Related]  

  • 12. Chemotherapy of tuberculosis. I. Typical Mycobacterium tuberculosis--primary drugs.
    J Kans Med Soc; 1968 Sep; 69(9):445-8. PubMed ID: 4971623
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparative study of 2 therapeutic schemes in pulmonary tuberculosis not previously treated].
    Galleguillos F; Valenzuela P; Carrasco E; Ham O; Ihnen R
    Rev Med Chil; 1973 Jan; 101(1):25-9. PubMed ID: 4753547
    [No Abstract]   [Full Text] [Related]  

  • 14. ISONIAZID, PARA-AMINOSALICYLIC ACID, AND STREPTOMYCIN INTOLERANCE IN 1,744 PATIENTS. AN ANALYSIS OF REACTIONS TO SINGLE DRUGS AND DRUG GROUPS PLUS DATA ON MULTIPLE REACTIONS, TYPE AND TIME OF REACTIONS, AND DESENSITIZATION.
    BERTE SJ; DIMASE JD; CHRISTIANSON CS
    Am Rev Respir Dis; 1964 Oct; 90():598-606. PubMed ID: 14221672
    [No Abstract]   [Full Text] [Related]  

  • 15. [Bacteriological development in the triple combination antituberculosis treatment].
    Rodríguez A; Fernández E
    Rev Med Chil; 1966 Jul; 94(7):442-5. PubMed ID: 4169808
    [No Abstract]   [Full Text] [Related]  

  • 16. A national study to determine the prevalence of drug resistance in newly discovered previously untreated tuberculosis patients as well as in retreatment cases.
    Eidus L; Jessamine AG; Hershfield ES; Helbecque DM
    Can J Public Health; 1978; 69(2):146-53. PubMed ID: 657071
    [No Abstract]   [Full Text] [Related]  

  • 17. Aspects of the tuberculosis situation in Denmark, especially chemoresistance.
    Kok-Jensen A; Torning K
    Scand J Respir Dis Suppl; 1969; 69():17-20. PubMed ID: 4906371
    [No Abstract]   [Full Text] [Related]  

  • 18. [Tuberculostatic tolerance of a tuberculous kidney].
    Strauss I
    Z Urol Nephrol; 1969; 62(9):651-6. PubMed ID: 4325816
    [No Abstract]   [Full Text] [Related]  

  • 19. Drugs for tuberculosis.
    Br Med J; 1968 Sep; 3(5619):664-7. PubMed ID: 4175142
    [No Abstract]   [Full Text] [Related]  

  • 20. Tuberculosis and pneumoconiosis.
    Lancet; 1967 Aug; 2(7512):410. PubMed ID: 4166346
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.